Legen; Igor
Patent Applications and Registrations
Patent applications and USPTO patent grants for Legen; Igor.The latest application filed is for "crystalline form ii of darolutamide".
- Legen; Igor - Ljubljana SI
- Legen; Igor - Grosuplje SI
| Patent | Date |
|---|---|
| Crystalline Form II of Darolutamide App 20210087175 - Adamer; Verena ; et al. | 2021-03-25 |
| Apparatus for simulating the function of human stomach and/or human intestine Grant 10,127,839 - Legen , et al. November 13, 2 | 2018-11-13 |
| Pharmaceutical composition Grant 9,707,178 - Avanzo , et al. July 18, 2 | 2017-07-18 |
| Pharmaceutical composition Grant 9,622,976 - Beso , et al. April 18, 2 | 2017-04-18 |
| Apparatus For Simulating The Function Of Human Stomach And/Or Human Intestine App 20160351079 - Legen; Igor ; et al. | 2016-12-01 |
| Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media Grant 8,753,681 - Legen , et al. June 17, 2 | 2014-06-17 |
| Pharmaceutical Composition App 20140134247 - Beso; Adnan ; et al. | 2014-05-15 |
| Pharmaceutical composition Grant 8,685,452 - Beso , et al. April 1, 2 | 2014-04-01 |
| Coated formulations for tolterodine Grant 8,642,078 - Legen , et al. February 4, 2 | 2014-02-04 |
| Self-microemulsifying drug delivery systems Grant 8,592,490 - Legen , et al. November 26, 2 | 2013-11-26 |
| Controlled Release Pharmaceutical Compositions Comprising O-desmethyl-venlafaxine App 20120027857 - Abramovic; Zrinka ; et al. | 2012-02-02 |
| Active Coating Of Pharmaceutical Dosage Forms App 20120009227 - Humar; Vlasta ; et al. | 2012-01-12 |
| Sirolimus formulation Grant 8,053,444 - Reven , et al. November 8, 2 | 2011-11-08 |
| Single Dosage Pharmaceutical Formulation Comprising Eprosartan Mesylate App 20110135738 - Legen; Igor ; et al. | 2011-06-09 |
| Tablet Comprising Eprosartan Mesylate App 20110112160 - Legen; Igor ; et al. | 2011-05-12 |
| Self-microemulsifying Drug Delivery Systems App 20100331356 - Legen; Igor ; et al. | 2010-12-30 |
| Pharmaceutical Composition Comprising At Least One Active Agent And A Binder, Which Swells In An Acidic Media App 20100297227 - Legen; Igor ; et al. | 2010-11-25 |
| Pharmaceutical Composition App 20090238871 - Avanzo; Matej ; et al. | 2009-09-24 |
| Coated Formulations For Tolterodine App 20090214642 - Legen; Igor ; et al. | 2009-08-27 |
| Pharmaceutical Composition App 20090202636 - Beso; Adnan ; et al. | 2009-08-13 |
| Pharmaceutical composition comprising eszoplicone App 20080299193 - Jerala-Strukelj; Zdenka ; et al. | 2008-12-04 |
| Sirolimus Formulation App 20080176888 - Reven; Sebastjan ; et al. | 2008-07-24 |
| Pharmaceutical Composition Containing Candesartan Cilexetil as Lipophilic Crystalline Substance App 20080118564 - Jerala-Strukelj; Zdenka ; et al. | 2008-05-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 